Rare SP-A alleles and the SP-A1-6A4 allele associate with risk for lung carcinoma

Clinical Genetics

Volumn 68, Issue 2, 2005, Pages 128-136

  Seifart, Carola ^a   Lin, H M ^b   Seifart, U ^a   Plagens, A ^a   DiAngelo, S ^c   von Wichert, P ^a   Floros, J ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Lung cancer; Polymorphism; Squamous cell carcinoma; Surfactant protein

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN A1; SURFACTANT PROTEIN A2; SURFACTANT PROTEIN B; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RISK FACTORS; VARIATION (GENETICS);

EID: 22244484425     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00470.x     Document Type: Article

References (68)

1. Amos CI, Xu W, Spitz MR. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 1999: 151: 3-12.
2. Petty TL. Lung cancer and chronic obstructive pulmonary disease. Hematol Oncol Clin North Am 1997: 11: 531-541.
3. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986: 105: 503-507.
4. Malkinson AM, Bauer A, Meyer A et al. Experimental evidence from an animal model of adenocarcinoma that chronic inflammation enhances lung cancer risk [In Process Citation]. Chest 2000: 117: 228S.
5. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999: 160: 1668-1672.
6. Rennard SI. Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999: 160: S12-S16.
7. Floros J, Phelps DS. Pulmonary surfactant. In: Biebuck J, Lynch III C, Maze M, Saidman LJ, Yaksh TL, Zapol WM, eds. Anesthesia Biologic Foundations: Lippincott-Raven 1997, 1259-1279.
8. Morgenroth K, Bolz J. Morphological features of the interaction between mucus and surfactant on the bronchial mucosa. Respiration 1985: 47: 225-231.
9. Yoneda K. Mucous blanket of rat bronchus: an ultrastructural study. Am Rev Respir Dis 1976: 114: 837-842.
10. Gehr P, Geiser M, Im Hof V, Schurch S, Waber U, Baumann M. Surfactant and inhaled particles in the conducting airways: structural, stereological, and biophysical aspects. Microsc Res Tech 1993: 26: 423-436.
11. Allegra L, Bossi R, Braga P. Influence of surfactant on mucociliary transport. Eur J Respir Dis Suppl 1985: 142: 71-76.
12. Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998: 1408: 312-322.
13. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 2001: 20: 269-292.
14. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001: 63: 521-554.
15. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002: 109: 707-712.
16. Floros J, Phelps DS. Pulmonary surfactant protein A; structure, expression, and its role in innate host defense. In: Nakos G, Lekka ME, eds. Surfactant-Update of Intensive Care Medicine. Ioannina, Greece: University of Ioannina, 2002, 87-102.
17. Batenburg JJ, Haagsman HP. The lipids of pulmonary surfactant: dynamics and interactions with proteins. Prog Lipid Res 1998: 37: 235-276.
18. Kremlev SG, Phelps DS. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol 1994: 267: L712-L719.
19. Kremlev SG, Phelps DS. Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line. Am J Physiol 1997: 272: L1070-L1077.
20. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998: 19: 700-708.
21. Crouch EC. Structure, biologic properties, and expression of surfactant protein D (SP-D). Biochim Biophys Acta 1998: 1408: 278-289.
22. DiAngelo S, Lin Z, Wang G et al. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999: 15: 269-281.
23. Floros J, DiAngelo S, Koptides M et al. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol 1996: 15: 489-498.
24. Voss T, Melchers K, Scheirle G, Schafer KP. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences. implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol 1991: 4: 88-94.
25. Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 2004: 43: 4227-4239.
26. Garcia-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry 2002: 41: 14041-14053.
27. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 2002: 110: 79-84.
28. Wang G, Phelps DS, Umstead TM, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 2000: 278: L946-L954.
29. Clark JC, Wert SE, Bachurski CJ et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995: 92: 7794-7798.
30. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993: 328: 406-410.
31. Clark JC, Weaver TE, Iwamoto HS et al. Decreased lung compliance and air trapping in heterozygous SP-B- deficient mice. Am J Respir Cell Mol Biol 1997: 16: 46-52.
32. Tokieda K, Iwamoto HS, Bachurski C et al. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury [see comments]. Am J Respir Cell Mol Biol 1999: 21: 463-472.
33. Karinch AM, deMello DE, Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 1997: 321: 39-47.
34. Wang G, Guo X, Floros J. Human SP-A-3′-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 2003: 284: L738-L748.
35. Hoover RR, Floros J. SP-A-3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol 1999: 276: L917-L924.
36. Selman M, Lin HM, Montano M et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 2003: 113: 542-550.
37. Floros J, Kala P. Surfactant proteins: molecular genetics of neonatal pulmonary diseases. Annu Rev Physiol 1998: 60: 365-384.
38. Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000: 9: 2751-2760.
39. Kala P, TenHave T, Nielsen H, Dunn M, Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 1998: 43: 169-177.
40. Floros J, Fan R, Diangelo S, Guo X, Wert J, Luo J. Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr Int 2001: 43: 567-576.
41. Floros J, Lin HM, Garcia A et al. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 2000: 182: 1473-1478.
42. Guo X, Lin HM, Lin Z et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001: 18: 482-490.
43. Seifart C, Plagens A, Brodje D, Muller B, von Wichert P, Floros J. Surfactant protein B intron 4 variation in German patients with COPD and acute respiratory failure. Dis Markers 2002: 18: 129-136.
44. Seifart C, Seifart U, Plagens A, Wolf M, Von Wichert P. Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients. Br J Cancer 2002: 87: 212-217.
45. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004: 13: 1095-1104.
46. Lin Z, Pearson C, Chinchilli V et al. Polymorphisms of human SP-A, SP-B, and SP - D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000: 58: 181-191.
47. Agudo A, Ahrens W, Benhamou E et al. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int J Cancer 2000: 88: 820-827.
48. Lin Z, deMello DE, Wallot M, Floros J. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4. Mol Genet Metab 1998: 64: 25-35.
49. Kala P, Koptides M, Diangelo S et al. Characterization of markers flanking the human SP-B locus. Dis Markers 1997: 13: 153-167.
50. Karinch AM, Floros J. 5′ splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 1995: 12: 77-88.
51. Lewis PO, Zaykin D. Genetic Data Analysis. Computer Program for the Analysis of Allelic Data, Version 1.0 (d16c). Free program distributed by the authors over the internet from 2001, http://lewis.eeb.uconn.edu/lewishome/software.html.
52. Ross JA, Rosen GD. The molecular biology of lung cancer. Curr Opin Pulm Med 2002: 8: 265-269.
53. Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001: 98: 13790-13795.
54. Garber ME, Troyanskaya OG, Schluens K et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001: 98: 13784-13789.
55. Finley TN, Ladman AJ. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med 1972: 286: 223-227.
56. Low RB, Davis GS, Giancola MS. Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am Rev Respir Dis 1978: 118: 863-875.
57. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps D, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2005: 288: L150-L158.
58. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996: 109: 1006-1009.
59. Floros J, Phelps DS, deMello DE et al. The utility of postmortem lung for RNA studies; variability and correlation of the expression of surfactant proteins in human lung. Exp Lung Res 1991: 17: 91-104.
60. Bauer AK, Malkinson AM, Kleeberger SR. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Mol Physiol 2004: 287: L685-L703.
61. Sueoka N, Suganuma M, Sueoka E et al. A new function of green tea: prevention of lifestyle-related diseases. Ann NY Acad Sci 2001: 928: 274-280.
62. Khubchandani KR, Goss KL, Engelhardt JF, Snyder JM. In situ hybridization of SP-A mRNA in adult human conducting airways. Pediatr Pathol Mol Med 2001: 20: 349-366.
63. Saitoh H, Okayama H, Shimura S, Fushimi T, Masuda T, Shirato K. Surfactant protein A2 gene expression by human airway submucosal gland cells. Am J Respir Cell Mol Biol 1998: 19: 202-209.
64. Koptides M, Umstead TM, Floros J, Phelps DS. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am J Physiol 1997: 273: L382-L388.
65. Janic B, Umstead TM, Phelps D, Floros J. Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation. Am J Physiol Lung Cell Mol Physiol 2005: 288: L317-L325.
66. Song M, Phelps DS. Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line. Infect Immun 2000: 68: 6611-6617.
67. Pikarsky E, Porat RM, Stein I et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004: 431: 461-466.
68. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996: 14: 374-379.